- Market Capitalization, $K 788,906
- Shares Outstanding, K 381,114
- Annual Sales, $ 91,900 K
- Annual Income, $ -168,730 K
- 60-Month Beta 1.30
- Price/Sales 8.58
- Price/Cash Flow N/A
- Price/Book 0.75
|Period||Period Low||Period High||Performance|
| || |
+0.19 (+10.05%)since 11/07/23
| || |
unch (unch)since 09/07/23
| || |
-0.81 (-28.03%)since 12/07/22
Despite economic challenges, the agricultural sector is set to stay strong with ongoing government support, advanced technology integration, and a focus on innovation aimed toward operational efficiency....
CRON earnings call for the period ending September 30, 2023.
Discover three cannabis stocks with significant growth potential, and learn why analysts favor these names over Canopy Growth.
EQNX::TICKER_START (OTCQB:LBUY),(NASDAQ:SNDL),(NASDAQ:TLRY),(NASDAQ:CGC),(NASDAQ:CRON) EQNX::TICKER_END
/PRNewswire/ -- The global cannabis markets has been growing in recent years and is expected to continue through this decade. Marijuana legalization is gaining...
CGC has nearly tripled since late August - and now these three marijuana stocks have more upside potential, according to Wall Street.
A trio of catalysts pushed these pot stocks higher this week.
There's some potentially very good news coming soon from the halls of Congress.
Cannabis stocks could deliver outsized gains if marijuana is rescheduled, per a recent HHS recommendation. While the DEA weighs its options, here's a look at three names with significant upside potential,...
Numerous cannabis stocks surged after a government agency recommended removing marijuana from Schedule 1, potentially paving the way for industry growth.